Herein, we confirmed the anti-hyperglycemic effect of SGLT2i in a genetic model of obesity represented by the ob/ob leptin-deficient mice, but we reported a reduction of blood glucose levels after treatment also in wild-type lean animals. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.